3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
4
Neuroblastoma
3
Medulloblastoma
2
Carcinoid Tumor
2
von Hippel-Lindau Disease
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Prostatic Neoplasms
1
Parathyroid Neoplasms
1
Paraganglioma
1
Multiple Endocrine Neoplasia
1
Hypoglycemia
1
Hyperparathyroidism
1
Hypercalcemia
1
Cancer Diagnosis
1
Interventions
Everolimus
5
Topotecan
2
Etoposide
2
Cisplatin
2
Bevacizumab
2
veliparib
1
pralsetinib
1
pertuzumab
1
pembrolizumab
1
pasireotide
1
lenvatinib
1
carfilzomib
1
cabozantinib
1
berzosertib
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Radiosurgery
1
Podophyllotoxin
1
Platinum
1
Octreotide
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Neuroendocrine
×
gallium Ga 68 dotatate
×
Clear all
No trials found.